Bunyamin Ozgeris

Bunyamin Ozgeris

Auto-generated profile, based on publicly available information

Bunyamin Ozgeris

Erzurum Technical University

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2016 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
BÖBünyamin Özgeriş
Bünyamin Özgeriş
SGSüleyman Göksu
Süleyman Göksu
LKLeyla Polat Köse
Leyla Polat Köse
Ilhami GulcinIlhami Gulcin
Ilhami Gulcin
Ramin Ekhteiari SalmasRamin Ekhteiari Salmas
Ramin Ekhteiari Salmas
Claudiu SupuranClaudiu Supuran
Claudiu Supuran

10 November 2016 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PDF file
KAKadir Aksu
Kadir Aksu
BÖBünyamin Özgeriş
Bünyamin Özgeriş
PTParham Taslimi
Parham Taslimi
ANAli Naderi
Ali Naderi
IGİlHami Gülçin
İlHami Gülçin
SGSüleyman Göksu
Süleyman Göksu

16 February 2015 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
PTParham Taslimi
Parham Taslimi
Ilhami GulcinIlhami Gulcin
Ilhami Gulcin
BOBunyamin Ozgeris
Bunyamin Ozgeris
SGSuleyman Goksu
Suleyman Goksu
FTFerhan Tumer
Ferhan Tumer
CSClaudiu T. Supuran
Claudiu T. Supuran
Carbonic anhydrases (CAs, EC 4.2.1.1) had six genetically distinct families described to date in various organisms. There are 16 known CA isoforms in humans. Human CA isoenzymes I and II (hCA I and hCA II) are ubiquitous cytosolic isoforms. Acetylcholine esterase (AChE. EC 3.1.1.7) is a hydrolase that hydrolyzes the neurotransmitter acetylcholine relaying the signal from the nerve. In this study, some trimethoxyindane derivatives were investigated as inhibitors against the cytosolic hCA I and II isoenzymes, and AChE enzyme. Both hCA isozymes were inhibited by trimethoxyindane derivatives in the low nanomolar range. These compounds were good hCA I inhibitors (Kis in the range of 1.66–4.14 nM) and hCA II inhibitors (Kis of 1.37–3.12 nM) and perfect AChE inhibitors (Kis in the range of 1.87–7.53 nM) compared to acetazolamide as CA inhibitor (Ki: 6.76 nM for hCA I and Ki: 5.85 nM for hCA II) and Tacrine as AChE inhibitor (Ki: 7.64 nM).

17 March 2016 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
SYSüleyman Yılmaz
Süleyman Yılmaz
YAYusuf Akbaba
Yusuf Akbaba
BÖBünyamin Özgeriş
Bünyamin Özgeriş
LKLeyla Polat Köse
Leyla Polat Köse
SGSüleyman Göksu
Süleyman Göksu
Claudiu SupuranClaudiu Supuran
Claudiu Supuran
A series of carbamate derivatives were synthesized and their carbonic anhydrase I and II isoenzymes and acetylcholinesterase enzyme (AChE) inhibitory effects were investigated. All carbamates were synthesized from the corresponding carboxylic acids via the Curtius reactions of the acids with diphenyl phosphoryl azide followed by addition of benzyl alcohol. The carbamates were determined to be very good inhibitors against for AChE and hCA I, and II isoenzymes. AChE inhibition was determined in the range 0.209–0.291 nM. On the other hand, tacrine, which is used in the treatment of Alzheimer’s disease possessed lower inhibition effect (Ki: 0.398 nM). Also, hCA I and II isoenzymes were effectively inhibited by the carbamates, with inhibition constants (Ki) in the range of 4.49–5.61 nM for hCA I, and 4.94–7.66 nM for hCA II, respectively. Acetazolamide, which was clinically used carbonic anhydrase (CA) inhibitor demonstrated Ki values of 281.33 nM for hCA I and 9.07 nM for hCA II. The results clearly showed that AChE and both CA isoenzymes were effectively inhibited by carbamates at the low nanomolar levels.


1 March 2021 in Russian Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
BÖB. Özgeriş
B. Özgeriş
Thiourea-based scaffolds are increasingly used in medicinal chemistry owing to their tunable structural properties. This study demonstrates the first examples of phenethylamine-based thiourea derivatives and their antimicrobial and antioxidant activities. All compounds exhibited strong antibacterial activity against tested bacteria known to cause nosocomial infections, which have acquired resistance to many antibiotics, and also strong antioxidant properties. Therefore, they can be evaluated as possible antibacterial and antioxidant agents in the treatment of bacterial infections and many health problems related to aging.